Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04613596 |
|---|---|
| Brief Title: | Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 |
| First Submitted : | October 28, 2020 |
| First Submitted that Met QC Criteria : | October 30, 2020 |
| First Posted : | November 3, 2020 |
| Last Update Submitted that Met QC Criteria : | April 22, 2024 |
| Last Update Posted : | April 24, 2024 |